Neogen (NASDAQ:NEOG) Announces Quarterly Earnings Results

Neogen (NASDAQ:NEOG - Get Free Report) posted its earnings results on Wednesday. The company reported $0.10 EPS for the quarter, missing analysts' consensus estimates of $0.12 by ($0.02), RTT News reports. Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. The firm had revenue of $221.00 million for the quarter, compared to the consensus estimate of $225.27 million. During the same quarter in the prior year, the company posted $0.12 earnings per share. The firm's revenue was down 3.4% compared to the same quarter last year. Neogen updated its FY 2025 guidance to EPS.

Neogen Trading Down 0.5 %

Shares of NEOG traded down $0.03 during midday trading on Monday, hitting $5.55. The stock had a trading volume of 2,230,776 shares, compared to its average volume of 2,542,255. Neogen has a 1 year low of $3.87 and a 1 year high of $18.58. The company has a debt-to-equity ratio of 0.33, a current ratio of 3.77 and a quick ratio of 2.46. The stock's 50 day moving average is $9.08 and its 200 day moving average is $11.93. The firm has a market cap of $1.20 billion, a PE ratio of -2.53 and a beta of 1.57.

Insider Buying and Selling

In other Neogen news, CAO John Patrick Moylan bought 10,000 shares of the business's stock in a transaction dated Thursday, April 10th. The shares were purchased at an average price of $5.07 per share, with a total value of $50,700.00. Following the completion of the purchase, the chief accounting officer now owns 10,000 shares in the company, valued at $50,700. This represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO David H. Naemura acquired 14,800 shares of the company's stock in a transaction that occurred on Thursday, January 16th. The shares were acquired at an average price of $11.11 per share, with a total value of $164,428.00. Following the acquisition, the chief financial officer now owns 61,434 shares in the company, valued at $682,531.74. This trade represents a 31.74 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 47,835 shares of company stock valued at $469,204. Company insiders own 1.13% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Guggenheim lowered their price objective on shares of Neogen from $15.00 to $13.00 and set a "buy" rating for the company in a research report on Thursday. Piper Sandler lowered their price target on shares of Neogen from $13.00 to $6.50 and set a "neutral" rating for the company in a report on Monday.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.